The Genetics of Frontotemporal Dementia and Related Disorders
Journal:
Current Genomics
Volume:
1
Page:
339-352
Author(s):
M. J. Sobrido, M. Wiedau-Pazos and D. H. Geschwind
Conantokins Inhibitors of Ion Flow through the N-Methyl-D-Aspartate Receptor Channels
Journal:
Current Drug Targets
Volume:
1
Page:
219-235
Author(s):
Francis J. Castellin and Mary Porok
COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1113-1120
Author(s):
C. Hoffmann
COX-2 Selectivity and Inflammatory Processes
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1145-1161
Author(s):
Joanne van Ryn, Gnnter Trummlitz and Michel Pairet
Current Problems with Non-Specific COX Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1693-1724
Author(s):
Patricia McGettigan and David Henry
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1755-1776
Author(s):
A. Yermakova and M. K. O'Banion
PET Studies of Brain Monoamine Transporters
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1611-1623
Author(s):
Aki Laakso and Jarmo Hietala
Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Journal:
Current Drug Metabolism
Volume:
1
Page:
193-204
Author(s):
B. Widner, M. Ledochowski and D. Fuchs
Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Journal:
Current Drug Targets
Volume:
1
Page:
163-183
Author(s):
Charleata A. Carter
Modulation of the Ceramide Level, A Novel Therapeutic Concept
Journal:
Current Drug Targets
Volume:
1
Page:
185-205
Author(s):
R. Claus, S. Russwurm, M. Meisner, R. Kinscherf and H. P. Deigner